Salmeterol Prescription Medicines in the Philippines

KOVENT SF Salmeterol / Fluticasone 25 / 250 Inhaler is used for the regular maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). This combination is appropriate for individuals whose condition is not sufficiently managed by a standard inhaled corticosteroid alone, or for those already adequately controlled on both a long-acting beta-agonist and an inhaled corticosteroid. It works to reduce airway inflammation and keep the breathing tubes open, leading to improved airflow. This preparation is strictly for maintenance therapy and must not be used for sudden, acute breathing attacks.

AROFLO-125 Salmeterol / Fluticasone 25 / 125 Inhaler is used for the regular treatment of asthma in adults and adolescents when a combination of a long-acting bronchodilator and an inhaled corticosteroid is necessary for disease management. It is also indicated for the symptomatic management of moderate to severe Chronic Obstructive Pulmonary Disease (COPD) to improve breathing and reduce flare-ups. The dual action of the ingredients reduces inflammation and relaxes the muscles in the airways, promoting better airflow. However, this product is intended for maintenance therapy and should not be used for immediate relief of sudden, acute breathing difficulties.

AROFLO-250 Salmeterol / Fluticasone 25 / 250 Inhaler is used for the regular treatment of asthma in adults and adolescents where a combination therapy of a long-acting bronchodilator and an inhaled corticosteroid is considered appropriate for effective symptom control. This higher strength is also indicated for the symptomatic treatment of adult patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) who continue to experience significant symptoms despite standard bronchodilator therapy. The medicine works by relaxing the airway muscles and reducing inflammation in the lungs to help improve breathing. It is essential to remember that this product is for maintenance treatment and must not be used to treat a sudden, acute attack of breathlessness.